Allele Biotechnology and Pharmaceuticals, Inc. v. Regeneron Pharmaceuticals, Inc.
Case Number:
7:20-cv-08255
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
- 
						December 16, 2024
						Allele, Regeneron Settle COVID Treatment Patent SuitAllele Biotechnology and Regeneron Pharmaceuticals have settled litigation accusing the latter of infringing a patent used in developing treatments and vaccines for COVID-19, a New York federal judge said Monday. 
- 
						October 04, 2024
						Regeneron Can't Ax Willful Infringement In COVID Patent CaseRegeneron Pharmaceuticals Inc. cannot boot a willful infringement claim from Allele Biotech's patent suit over the development of COVID-19 vaccines and treatments, a New York federal judge ruled Friday, saying it was up to Regeneron to establish that Allele failed to show the defendant had presuit knowledge of the patent. 
- 
						September 19, 2023
						Regeneron Partly Agrees It Infringed COVID Tech PatentRegeneron Pharmaceuticals Inc. has agreed in part that it infringed a California company's patent when developing and testing COVID-19 vaccines and treatments, although it maintained that any liability it may have would not extend to activities covered by a federal safe harbor. 
- 
						March 02, 2022
						Regeneron Can't Ditch COVID-19 Tech Patent SuitRegeneron Pharmaceuticals Inc. can't escape a suit claiming it used poached technology in its development and testing of COVID-19 vaccines and treatments, a New York federal judge ruled Wednesday. 
- 
						August 20, 2021
						Regeneron Wants COVID-19 Tech Patent Suit AxedRegeneron Pharmaceuticals Inc. wants a New York federal judge to toss a suit claiming it used poached technology in its development and testing of COVID-19 vaccines and treatments, saying the company is protected by a legal safe harbor. 
- 
						October 09, 2020
						COVID-19 IP Catch-Up: Moderna Promises & Ed SheeranIn this round of intellectual property updates tied to the COVID-19 pandemic, Moderna said it would hold off on enforcing certain patents and Ed Sheeran said getting to the U.S. for a copyright trial may be impossible, among many other litigation updates. 
- 
						October 05, 2020
						Pfizer, Regeneron Hit With Patent Suits Over COVID-19 TechPfizer Inc. and Regeneron Pharmaceuticals Inc. were accused Monday of using poached technology in their development and testing of COVID-19 vaccines and treatments, according to a pair of patent infringement suits lodged in California and New York federal court.